ClinicalTrials.gg
Status unknownNCT06440928Updated Jun 4, 2024

Results of Cervical Segmental Mobilization in Patients With Chronic Lateral Epicondylitis

An interventional study of mobilization and standard treatment in Epicondylitis of the Elbow and Servical Segmental Mobilization, sponsored by Halic University. Status unknown at 1 site in Turkey (Türkiye). Open to participants aged 25 Years to 44 Years. Per ClinicalTrials.gov, last updated 2024-06-04.

Sponsored by Halic University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified May 2024), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
25 Years to 44 Years
Sex
All
01

Study summary

The aim of our study was to investigate the effect of cervical segmental mobilization on pain, functionality, grip strength and quality of life in patients with chronic lateral epicondylitis. It was planned as a randomized controlled experimental study.

02

Conditions studied

  • Epicondylitis of the Elbow
  • Servical Segmental Mobilization

Keywords

  • Lateral epicondylitis
  • Servical segmental mobilization
  • Pain
  • Quality of life
  • Grip strenght
  • Functionality
03

In context

Tennis Elbow

296 studies on the registry are indexed under Tennis Elbow; 63 are open to participants now.

This study's planned enrollment of 36 is below the median of 50 across 263 interventional studies indexed under Tennis Elbow.

Browse Tennis Elbow studies →

Lead sponsor

Halic University is the lead sponsor of 83 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 44 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between the ages of 25-44
  • Being diagnosed with LE by a physician
  • Not having any defined pathology in the cervical region
  • No neurological problems in the upper extremities
  • No history of cervical surgery

Exclusion criteria

Exclusion Criteria:

  • Those with a history of infection, tumor, trauma in the cervical area
  • Fibromyalgia patients
  • Congenital or acquired deformities of the upper extremity
  • History of shoulder or elbow surgery or dislocation
  • Cervical radiculopathy
  • Having had Wiplash
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    intervention grup: standart treatment and segmental mobilization grup

    Mobilisation specifically on the C7 segment will be performed by the physiotherapist 2 times a week for 3 weeks, making decisions on the choice of key parameters including treatment technique, spinal level, degree, direction, side and duration.

    Behavioral: mobilization · Other: standard treatment

  • Experimental
    intervention grup : standart treatment and deep friction

    The patients were asked to stretch for 20 s with the other hand with the shoulder in internal rotation, elbow in extension, forearm in pronation, wrist in flexion and ulnar deviation. In the first week, stretching exercises were recommended to be performed 3 sets a day, 5⨯20 s in one set and 45 s rest interval before strengthening exercises. The application will be performed with the thumb in the transverse direction, with the pressure tolerated by the individual, for 10 minutes after numbness is obtained, the treatment lasts approximately 10-15 minutes.

    Other: standard treatment · Other: deep friction

  • Experimental
    intervention grup: standart treatment.

    The patients were asked to stretch for 20 s with the other hand with the shoulder in internal rotation, elbow in extension, forearm in pronation, wrist in flexion and ulnar deviation. In the first week, stretching exercises were recommended to be performed 3 sets a day, 5⨯20 s in one set and 45 s rest interval before strengthening exercises. Starting from the 2nd week of treatment, it will be requested to be performed 3 sets a day, 5⨯20 s in one set, 5⨯20 s before exercise and 5⨯20 s after exercise.

    Other: standard treatment

Interventions

  • Behavioralmobilization

    mobilization and exercise to be applied to patients with chronic lateral epicondylitis

    Also known as: excersize

  • Otherstandard treatment

    standard treatment

  • Otherdeep friction

    deep friction

06

What researchers measure

Primary outcomes

  1. Assessment of Pain

    In the assessment of pain, the "Visuel Analog Scale (VAS)" will be used and people will be asked to indicate the severity of their pain in the last 24 hours on a 10 cm chart. Before and after the session, VAS will be evaluated and recorded with the values measured with algometer. According to the pain scale in VAS application; "0" means no pain and "10" means the presence of unbearable pain, while patients will be asked to mark the pain they feel numerically between 0-10.

    Time frame: 3 weeks

  2. Quality of Life Short Form-36

    The scale consists of 36 statements. The scale has 8 dimensions including physical functioning (FF), social functioning (SF), role limitations related to physical functioning (RRF), role limitations related to emotional problems (ERR), mental health (MS), vitality (C), bodily pain (BA) and general health perception (GS). Quality of life increases as the scores on the scale increase. Minimum score is 0 and maximum score is 100.

    Time frame: 3 weeks

  3. Assessment of Functionality

    Duruöz Hand Index (DEI) specifically for rheumatoid arthritis patients. The index includes hand dexterity in the kitchen, during dressing, while maintaining personal hygiene, at work and other general movements. Participants rate 18 items from 0 (no difficulty) to 5 (impossible to do). The total score ranges from 0-90. A high score indicates impaired hand function.

    Time frame: 3 weeks

  4. Grip Strength

    Grip strength will be evaluated with Jamar Hand Dynamometer. In the grip strength evaluations of the hand, measurements will be taken from both the patient and the healthy side. In the measurements made from the patient side, painless grip strength and maximum grip strength will be evaluated separately in the elbow flexion position and elbow extension position. On the healthy side, maximum grip strength will be evaluated in both positions. Patients will be positioned and evaluated according to the holding and gripping force of the dynamometer to be used. The patient will be asked to squeeze the dynamometer as strongly as possible for 5 seconds, first with the intact and then with the affected side, and 3 measurements will be made with one-minute breaks between the measurements and the averages will be recorded.

    Time frame: 3 weeks

07

Study locations

1 of 1 sites recruiting
  • Yalova University
    Yalova, Turkey (Türkiye)
    • Mustafa Yığılıtaş, Doctorate · Contact · 05309782720
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06440928
Lead sponsor
Halic University
Responsible party
Mustafa Yığılıtaş (lecturer, Halic University) — Principal investigator
First posted
Jun 4, 2024
Start date
May 15, 2024
Primary completion
Aug 15, 2024 (estimated)
Completion
Oct 15, 2024 (estimated)
Last update
Jun 4, 2024

Study contacts

mustafa yığılıtaş, doctorate
Contact
fztmy77@hotmail.com
05309782720
seda saka, asst.prof
Contact
seda.saka@halic.edu.tr

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion